LINOTAR

Relief of Psoriasis

Coal tar has been used effectively to treat psoriasis for more than 50 years but has been plaqued by being a messy product to apply. Linotar Gel  was first introduced  in South Africa when it was registered with the Medicines Control Council and it was the first new generation,  cosmetically  acceptable coal tar product with an improved efficacy (3,4,5,6).

Since then it has also been registered in a number of countries through a network of marketing partners. In the USA, Canada, the United Kingdom, Holland, Singapore Greece  and Austria permission to market the brand as Exorex was granted by the relevant regulatory authorities. In Australia both brand names exist.

A number of international clinical studies have testified to the efficacy of Linotar™/Exorex™ and it is prudent to quote the editor of the Journal of Dermatological Treatment (3) when  he referred to the value of products that have stood the test of time and called them “ tried and trusted” friends .

He said ” Coal tar is one such old friend that is at risk of becoming distinctly unfashionable in the era of biologics, but I would suggest that we ignore it at our peril. It has the benefit of a long safety record and many patients have used it to good effect over many years. Thus well-performed clinical research into the use of coal tar is welcome. In this issue, Goodfield and colleagues report on a large , randomized multi-center double-blind comparison of two coal tar products used for 12 weeks. Psoriasis improved significantly in both study groups with 40-49% reporting moderate or marked improvement and a few clearing completely.”  He further stated that:” It is perhaps surprising that the 1% tar preparation (Exorex/Linotar) was as  or more effective than a 5% formulation, and the authors speculate that the vehicle*  may play a role”

*a patented drug delivery system with the ability to entrap, transport and deliver pharmacologically active compounds, trade marked as emzaloid™

Benefits 

  • Easy of application  and quick absorption
  • Colourless and virtually odourless after application
  • No fragrances or colourants that can cause skin irritation
  • Suitable for all skin types
  • Suitable for treatment of  body, face and scalp
  • Essential fatty acids  help to restore normal skin and reduce inflammation
  • Will not stain clothing when properly applied
  • No known evidence that resistance is developed to the product

Reg Nr. 27/13.9.1/0357

Linotar is marketed by Activo Health in South Africa. For further information  contact Activo at  +27 (0) 12 460 9919 or go to : www.activo.co.za


Exorex links and/or contact information:

USA:
www.exorexusa.com

Canada:
www.exorex.ca

Exorex rangeUK:
Forest Laboratories (Europe)Contact Roopa Malhotra at: RMalhotra@forest-labs.co.uk or go to www.exorex.co.uk

Switzerland:
www.exorex.ch

Australia and New Zealand:
Actavis Pharmaceuticals
Contact: Sophie O’Brien at sophie.obrien@actavis.com